INBSNasdaq

Intelligent Bio Solutions Inc.

Healthcare·Healthcare·Commercial·New York, NY, United States

Intelligent Bio Solutions Inc. (INBS): 82 pipeline candidates · ~5 mo cash runway · 1 clinical trial. Updated within the last hour.

6.8/10

BioSniper Score

3-factor signal · derived from public data

Cash Runway1.5

5.4 months

Financial Health9.0

D/E 0.68 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

82 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for Intelligent Bio Solutions Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$5.4M

Cash

$6.9M

Quarterly Burn

$4.3M

Runway

5.4 mo

Revenue

$1.1M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Nov 2026
Today~7 mo out
Catalyst within runway

Pipeline (82 candidates)

Showing 10 of 82 candidates. Sign up for full pipeline.

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

7

Total value held

$711K

HolderSharesValue
armistice capital, llc130,000$435K
alyeska investment group, l.p.37,956$127K
geode capital management, llc28,609$96K
vanguard capital management llc11,620$39K
vanguard fiduciary trust co3,958$13K
osaic holdings, inc.200$670
curio wealth, llc200$669
1 clinical trial·CEO: Mr. Harry Simeonidis

Frequently asked questions

How many drug candidates are in Intelligent Bio Solutions Inc.'s pipeline?

Intelligent Bio Solutions Inc. (INBS) has 82 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Intelligent Bio Solutions Inc.'s cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Intelligent Bio Solutions Inc. has approximately 5.4 months of cash runway.

What is Intelligent Bio Solutions Inc.'s market capitalization?

Intelligent Bio Solutions Inc.'s market capitalization is approximately $5.4M.

Who is the CEO of Intelligent Bio Solutions Inc.?

Mr. Harry Simeonidis is the chief executive officer of Intelligent Bio Solutions Inc. (INBS).

Get the full picture on Intelligent Bio Solutions Inc.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.